It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it ...

Biomarker discovery opens the way for development of novel transformational technology in Autism Spectrum Disorder. FRAMINGHAM, MA / ACCESS Newswire / November 4, 2025 / Ignite Biomedical, Inc.

According to the agreement, Sanyou Bio will upgrade the development process through automation, substantially reducing the R&D timeline for innovative drugs. Through this strategic cooperation, Sanyou ...

Key opportunities in the preclinical CRO market lie in outsourcing R&D to streamline drug discovery and cut costs, with significant growth in AI-driven drug discovery. North America dominates, with ...

Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten ...

Eva-Maria Hempe, NVIDIA, says bio/pharma must centralize AI strategy, tackle silos, prioritize process integrity, and balance quick wins with long-term drug design goals.

POTOMAC, MARYLAND / ACCESS Newswire / November 3, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop i ...

Thomson, North America business development lead for healthcare and life sciences at NVIDIA, discusses how generative, ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...

Lantern today announced it will present two commercially deployed AI research platforms at the inaugural AI for Biology and Medicine (AI4BM) symposium at the University of North Texas. The symposium, ...

From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance ...